Details for Patent: 7,615,573
✉ Email this page to a colleague
Summary for Patent: 7,615,573
| Title: | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
| Abstract: | Disclosed is a novel enantiomeric synthesis ceramide-like inhibitors of UDP-glucose: N-acylsphingosine glucosyltransferase. Also disclosed are novel intermediates formed during the synthesis. |
| Inventor(s): | Siegel; Craig (Woburn, MA), Shayman; James A. (Ann Arbor, MI), Nelson; Carol A. (Westford, MA), Harris; David J. (Lexington, MA), Copeland; Diane P. (North Billerica, MA) |
| Assignee: | The Regents of the University of Michigan (Ann Arbor, MI) Genzyme Corporation (Cambridge, MA) |
| Application Number: | 11/702,425 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,615,573 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 7,615,573
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,615,573
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 554082 | ⤷ Try a Trial | |||
| Austria | 555102 | ⤷ Try a Trial | |||
| Brazil | 0211379 | ⤷ Try a Trial | |||
| Brazil | 122015016313 | ⤷ Try a Trial | |||
| Brazil | 122015016314 | ⤷ Try a Trial | |||
| Brazil | PI0211379 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
